Egnyte Announces New Offering for Early-Stage Life Science Startups


Egnyte announced it will be providing early-stage life sciences innovators complimentary access to their Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform.

Read more about the new offering here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.